Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Passage BIO, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 41 | 32 | −9 |
| SharesConverted for a 1-for-20 split | 1.75M | 1.65M | −103.9K (−5.9%) |
| Value | $13.0M | $13.2M | +$222.0K (+1.7%) |
New holders (6)
Institutions that held Passage BIO, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 23,500 | $188.2K | 0.00% |
| MAI Capital Management | 200 | $1.61K | 0.00% |
| Citigroup Inc | 77 | $617 | 0.00% |
| Parallel Advisors, LLC | 16 | $128 | 0.00% |
| Harbour Investments, Inc. | 3 | $24 | 0.00% |
| Northwestern Mutual Wealth Management Co | 2 | $16 | 0.00% |
Sold out (15)
Institutions that held Passage BIO, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| State Street Corp | 156,773 | $62.8K |
| RBF Capital, LLC | 142,807 | $57.2K |
| Northern Trust Corp | 112,056 | $44.9K |
| Simplex Trading, LLC | 82,983 | $33.0K |
| DLK Investment Management, LLC | 61,000 | $24.4K |
| XTX Topco Ltd | 60,889 | $24.4K |
| Two Sigma Investments, LP | 47,156 | $18.9K |
| Ritholtz Wealth Management | 25,392 | $10.2K |
| Mariner, LLC | 11,934 | $4.78K |
| Two Sigma Securities, LLC | 11,724 | $4.69K |
| Goldman Sachs Group Inc | 11,591 | $4.64K |
| Millennium Management LLC | 10,733 | $4.30K |
| Raymond James Financial Inc | 6,391 | $2.56K |
| Group One Trading, L.P. | 47 | $19 |
| Mid-American Wealth Advisory Group, Inc. | 32 | $13 |